![](/images/2013/post-sep.jpg)
Dry Eye Medication Market Size, Share, Revenue, Trends And Drivers For 2024-2033
The Business Research Company’s Dry Eye Medication Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
LONDON, GREATER LONDON, UK, July 19, 2024 /EINPresswire.com/ -- The dry eye medication market has experienced robust growth in recent years, expanding from $9.74 billion in 2023 to $10.93 billion in 2024 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to aging population, rising number of contact lens users, increase in disposable income, increase in number of treatment options, increase in number of allergies, rise in consumption of unhealthy or improper diets, and prevalence of diabetes mellitus.
Strong Future Growth Anticipated
The dry eye medication market is projected to continue its strong growth, reaching $16.93 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to rising laser surgeries, rising screen time, busy lifestyles, the increasing burden of diabetes, increase in prevalence of dry eye disease, promising pipeline for dry eye disease, and side effects of other medications.
Explore Comprehensive Insights Into The Global Dry Eye Medication Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=3807&type=smp
Growth Driver Of The Dry Eye Medication Market
The increased number of cases of dry eye disease results in an increased demand for its treatment. Factors such as aging, lack of vitamin A, wearing lenses, eye surgeries, direct contact with dry wind or smoke, and exposing one’s eyes to screens for a long duration increase the occurrence of the dry eye more likely.
Make Your Report Purchase Here And Explore The Whole Industry's Data As Well:
https://www.thebusinessresearchcompany.com/report/dry-eye-medication-global-market-report
Major Players And Market Trends
Key players in the dry eye medication market include Allergan PLC, Alcon Inc., Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co. Ltd., Santen Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd.
Major companies operating in the drugs for dry eye memarket are increasing their focus on introducing single-ingredient prescription eye drops such as Miebo to maximize revenue in the market. Miebo is a prescription eye drop used to treat the signs and symptoms of dry eye disease.
Segments:
1) By Type Of Product: Aqueous, Evaporative, Aqueous and Evaporative
2) By Delivery System: Liquid, Gel, Ointment, Other Delivery System
3) By Prescription Type: OTC Drugs, Prescription Drugs
4) By End-User: Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies
Geographical Insights: North America Leading The Market
North America was the largest region in the market in 2023. Middle East is expected to be the fastest-growing region in the global dry eye medication market share during the forecast period. The regions covered in the dry eye medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Dry Eye Medication Market Definition
Dry eye medication refers to the drugs or medication that is used to treat dry eye by increasing your eye moisture. A multifactorial condition of the tears and ocular surface known as dry eye causes symptoms such as pain, blurred vision, and tear film instability, as well as the possibility of ocular surface injury.
Dry Eye Medication Global Market Report 2024 from The Business Research Company covers the following information:
•Market size data for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Dry Eye Medication Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on dry eye medication market size, dry eye medication market drivers and trends, dry eye medication market major players, dry eye medication competitors' revenues, dry eye medication market positioning, and dry eye medication market growth across geographies. The dry eye medication market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Intraocular Lens Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intraocular-lens-global-market-report
Cosmetic Surgery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cosmetic-surgery-global-market-report
Ocular Implants Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ocular-implants-global-market-report
About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
![](https://health.einnews.com/tracking/article.gif?aid=728827583§ion=einpresswire&a=kRj8RKDymcND8LdY&i=wziQBtTpQSKpPueN)
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.